Alaris Medical
This article was originally published in The Gray Sheet
Executive Summary
Streamlining of operations announced July 7 is expected to save the infusion therapy system manufacturer approximately $6 mil. annually when fully implemented. The San Diego firm's Creedmoor, North Carolina facility will be restructured to include disposables engineering, distribution operations and automated manufacturing of selected products. Certain manual assembly operations will be moved to Tijuana, Mexico, while others will be outsourced. Job cuts will affect about 50 of the 750 jobs at the San Diego facility and less than 25 at a Basingstoke, England site
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.